Latest News and Press Releases
Want to stay updated on the latest news?
-
ETF outperforms S&P 500 by 11.34% in first year by seeking to eliminate losing stocks; Accumulates $78 million in assets NEW YORK, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The GraniteShares...
-
Edmonds, WA, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Depression suicide amongst veterans has always been a concern for policymakers. Research shows that, veterans have a 21% higher likelihood of suicide...
-
Edmonds, WA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- It is with great honor that Dr. Gregory Jantz is announcing the release of his latest book titled, Healing Depression for Life. The book is as...
-
YONKERS, NY--(Marketwired - Sep 30, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
-
YONKERS, NY--(Marketwired - Sep 24, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
-
YONKERS, NEW YORK--(Marketwired - Sep 19, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products...
-
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
-
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...